Cancer News and Research

Latest Cancer News and Research

Open Access publishing likely to become preferred option for cancer researchers

With researchers, authors and funders challenging the traditional journal publishing model, Open Access (OA) publishing is likely to become the preferred option, suggests a paper published in ecancermedicalscience.

13 Sep 2011

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Bayer HealthCare announced today that the company will present data on several of its investigational compounds at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

13 Sep 2011

FDA announces organizational changes within CDER's Office of Oncology Drug Products

Today, the U.S. Food and Drug Administration announced organizational changes within the office responsible for reviewing all drug and biologic applications for cancer therapies.

13 Sep 2011

New drug combination may treat two aggressive cancers

Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011.

13 Sep 2011

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.

13 Sep 2011

Researchers identify new type of potential anticancer drug

Researchers at Emory University School of Medicine have identified a new type of potential anticancer drug. The compound, named FOBISIN, targets 14-3-3 proteins, important for the runaway growth of cancer cells.

13 Sep 2011

George W. Bush Institute forms public-private partnership to combat cervical, breast cancers in developing world

The George W. Bush Institute is forming a public-private partnership to use PEPFAR's existing infrastructure of doctors, nurses and clinics to expand screening and treatment of women for cervical cancer and perform breast cancer education in the developing world, the Wall Street Journal reports.

13 Sep 2011

Cancer prevention tips for men at every stage of life

Men who maintain a healthy body throughout life are often better able to fight off diseases like cancer. That's why experts at The University of Texas MD Anderson Cancer Center have created a guide with cancer prevention tips to help men at every stage of life.

13 Sep 2011

Cardiotrophin 1 has marked effect on fat and glucose metabolism

Scientists from the Center for Applied Medical Research (CIMA) of the University of Navarra (Spain) have discovered that cardiotrophin 1, a protein synthesized by muscle cells and adipose tissue, has a marked effect on fat and glucose metabolism.

13 Sep 2011

New contraceptive website for young women

Friends, the mainstream media and the internet, all potentially unreliable sources, continue to be the way America's young adults find their health information. Research has found that while they trust health professionals and health educators, they often do not turn to them for information, especially when it comes to their sexual health.

13 Sep 2011

ASGE Endoscopy Unit Recognition Program honors 21 endoscopy units for safety and quality

The American Society for Gastrointestinal Endoscopy (ASGE) has recognized 21 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States.

13 Sep 2011

ImmunoCellular announces updated long-term data from ICT-107 Phase I trial on GBM

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced updated long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

13 Sep 2011

Breakthrough opens new avenues for hep C vaccine

Hopes for an effective vaccine and treatment against the potentially fatal hepatitis C virus (HCV) have received a major boost following the discovery of two ‘Achilles’ heels’ within the virus.

12 Sep 2011

Low-dose aspirin increases risk for GI bleeding

The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer.

12 Sep 2011

CEO Roundtable on Cancer bestows Gold Standard accreditation to Memorial Sloan-Kettering

Memorial Sloan-Kettering Cancer Center has received CEO Cancer Gold Standard accreditation, recognizing the center's commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for their own employees and their covered family members, as well as the patients whom they serve.

12 Sep 2011

Oncothyreon commences enrollment in PX-866 Phase 2 trial for metastatic castration-resistant prostate cancer

Oncothyreon Inc. today announced enrollment of the first patient in a Phase 2 trial of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.

12 Sep 2011

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Tensha Therapeutics announced today that it has raised $15 million in a Series A financing to advance the development of small molecule bromodomain inhibitors for the treatment of cancer and other conditions by regulating the transcription of disease-associated genes.

12 Sep 2011

Women with BRCA gene mutations at risk of developing cancers at earlier ages

A new analysis has found that women who develop certain hereditary cancers develop them at earlier ages than women in the previous generation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the results point to the importance of tracking younger ages of cancer diagnosis to determine when to provide counseling, screening, and treatment services.

12 Sep 2011

BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal women

BioSante Pharmaceuticals, Inc., today announced successful completion of its principal LibiGel (testosterone gel) pharmacokinetic (PK) study.

12 Sep 2011

Enrollment complete in HemaQuest HQK-1001 Phase 2 study in sickle cell disease

HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has completed enrollment in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.

12 Sep 2011

Cancer News and Research

Latest Cancer News and Research

Open Access publishing likely to become preferred option for cancer researchers

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

FDA announces organizational changes within CDER's Office of Oncology Drug Products

New drug combination may treat two aggressive cancers

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

Researchers identify new type of potential anticancer drug

George W. Bush Institute forms public-private partnership to combat cervical, breast cancers in developing world

Cancer prevention tips for men at every stage of life

Cardiotrophin 1 has marked effect on fat and glucose metabolism

New contraceptive website for young women

ASGE Endoscopy Unit Recognition Program honors 21 endoscopy units for safety and quality

ImmunoCellular announces updated long-term data from ICT-107 Phase I trial on GBM

Breakthrough opens new avenues for hep C vaccine

Low-dose aspirin increases risk for GI bleeding

CEO Roundtable on Cancer bestows Gold Standard accreditation to Memorial Sloan-Kettering

Oncothyreon commences enrollment in PX-866 Phase 2 trial for metastatic castration-resistant prostate cancer

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Women with BRCA gene mutations at risk of developing cancers at earlier ages

BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal women

Enrollment complete in HemaQuest HQK-1001 Phase 2 study in sickle cell disease

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in